Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
91 participants
INTERVENTIONAL
2014-02-28
2015-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Tolerance of Healthy Term Infants Fed Infant Formulas #3
NCT00977964
Healthy Term Infants Fed Milk-Based Infant Formula
NCT04529759
Growth and Tolerance of Healthy Term Infants Fed Cow's Milk-Based Infant Formulas
NCT02860026
Evaluation of Human Milk Fortifiers in Preterm Infants
NCT02307760
Tolerance of Healthy Term Infants Fed Infant Formulas
NCT00705562
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard Milk-based Formula Containing Carotenoid
milk-based ready to feed infant formula
Standard Milk-based Formula Containing Carotenoid
Fed ad libitum
Investigational Milk-based Formula Containing Carotenoid
investigational milk-based ready to feed infant formula
Investigational Milk-based Formula Containing Carotenoid
Fed ad libitum
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Standard Milk-based Formula Containing Carotenoid
Fed ad libitum
Investigational Milk-based Formula Containing Carotenoid
Fed ad libitum
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Infant is a singleton from a full term birth with a gestational age of 37-42 weeks
* Infant's birth weight was \> 2490 g (\~5 lbs 8 oz)
* Infant is between 14 and 28 days of age
* Parent(s) confirm intention to feed their infant the study product(s) as the sole source of nutrition for the duration of the study
* Parent(s) confirm intention not to administer vitamin or mineral supplements, DHA and ARA supplements, solid foods/juices to their infant from enrollment through the duration of the study
Exclusion Criteria
* Infants using medications (including OTC), home remedies, herbal preparations, probiotics or rehydration fluids that might affect gastrointestinal (GI) tolerance
14 Days
28 Days
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abbott Nutrition
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
John B Lasekan, PhD, CCRP
Role: STUDY_CHAIR
Abbott Nutrition
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tuscon Medical Center
Tuscon, Arizona, United States
Northpoint Pediatrics
Indianapolis, Indiana, United States
Midwest Children's Health Research Institute
Lincoln, Nebraska, United States
MetroHealth Medical Center
Cleveland, Ohio, United States
Dayton Clinical Research
Dayton, Ohio, United States
Institute of Clinical Research
Mayfield Heights, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AL13
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.